Most importantly, vinculin levels in urine from prostate cancer patients with relapse were higher than in urine from patients without relapse (median score without relapse 1.00; median with relapse 1.75; P = 0.229; median vinculin score in the control urine 0.250; P = 0.006). This evidence concerns the gene VCL and prostate cancer.